Metropolitan Life Insurance CO Wave Life Sciences Ltd. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.54 - $6.84 $2,343 - $4,528	662 Added 20.33%	3,918 $24,000
Q2 2023 Aug 10, 2023	BUY	$3.51 - $4.69 $11,428 - $15,270	3,256 New	3,256 $11,000
Q4 2020 Jun 22, 2023	BUY	$6.99 - $9.26 $77,547 - $102,730	11,094 New	11,094 $87.3 Million
Q3 2020 Jun 26, 2023	BUY	$8.49 - $19.54 $65,423 - $150,575	7,706 New	7,706 $65.4 Million
Q2 2020 Jun 26, 2023	BUY	$7.44 - $11.29 $55,390 - $84,054	7,445 New	7,445 $77.5 Million
Q1 2020 Jul 12, 2023	BUY	$6.94 - $14.22 $51,668 - $105,867	7,445 New	7,445 $69.8 Million
Q4 2019 Jul 12, 2023	BUY	$7.99 - $37.6 $55,498 - $261,169	6,946 New	6,946 $55.7 Million
Q3 2019 Jul 12, 2023	BUY	$19.17 - $27.4 $150,580 - $215,227	7,855 New	7,855 $161 Million
Q2 2019 Jul 12, 2023	BUY	$22.93 - $42.84 $138,795 - $259,310	6,053 New	6,053 $158 Million
Q1 2019 Jul 13, 2023	BUY	$32.69 - $47.91 $197,872 - $289,999	6,053 New	6,053 $235 Million

165

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.03B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.